HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA) - BioSpace
HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA) BioSpace
from "mma" - Google News https://ift.tt/2WeI37T
via IFTTT
from "mma" - Google News https://ift.tt/2WeI37T
via IFTTT
Comments
Post a Comment